Search
for
Sort by
Research 841–870 of 1000+
- Lipid-based liquid crystals as drug delivery vehicles for antimicrobial peptides
- Hypertension: sex-related differences in drug treatment, prevalence and blood pressure control in primary care
- In vitro hair follicle growth model for drug testing
- ER71/ETV2 Promotes Hair Regeneration from Chemotherapeutic Drug-Induced Hair Loss by Enhancing Angiogenesis
- Can an in vitro hair drug model be developed using dermal papilla cells alone?
- The pattern of off-label and unlicensed drug use in adult and pediatric patients in the Kingdom of Saudi Arabia: multicenter retrospective study
- Niosomes as Efficient Nanocarriers for Targeted Drug Delivery
- Management of Colorectal Cancer Using Nanocarriers-based Drug Delivery for Herbal Bioactives: Current and Emerging Approaches
- FDA declines approval of testosterone drug for third time
- Combining rapid degrading microneedles with Slow-Released drug delivery system for the treatment of alopecia areata
- Perspective Chapter: Appraisal of Paclitaxel (Taxol) Pros and Cons in the Management of Cancer – Prospects in Drug Repurposing
- Effect of Microneedling Associated With Drug Delivery on Facial Rejuvenation: Clinical and Histological Evaluation
- Tratamento de alopecia androgenética masculina com drug delivery por microagulhamento
- Acute Encephalomyelitis Syndromes Associated with H1N1 Influenza Vaccinations; Erythema Multiforme Secondary to H1N1 Vaccine; Cytolytic Hepatitis Possibly Related to Oral Contraceptives; Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) Syndrome Associated with Lamotrigine: First Report; Behavioral Disinhibition with Baclofen; Minoxidil-Induced Trichostasis Spinulosa of Terminal Hair; Delayed-Onset Mirtazapine-Related Leukopenia
- Potassium channels: new targets for drug treatment.
- Evolving CRBN ligands enhance the drug-like properties of protein degraders
- CD44/TRPV1 dual-targeted nanocarrier enables drug retention and multidimensional therapy for inflammatory skin diseases
- Chaotrope-Guided Protein Microneedles with High Drug-Loading Capacity, Ultrafast Dissolution, and High Mechanical Strength
- Sexual dimorphism of COVID-19 inspires drug repositioning and host-targeting immunotherapy for viral pneumonia
- Novel drugs of United States Food and Drug Administration approved in 2024
- TWEAK-conjugated selenoviologen as a novel photosensitizer for selective wound accumulation and synergistic healing of drug-resistant bacterial infections
- Hair Morphology: An Overlooked Variable in Alopecia Drug Trials
- Research Advances in Therapeutic Strategies and Drug Delivery Systems for Pathological Scars
- Engineered Bilayer Hydrogel with Spatiotemporal Drug and Oxygen Delivery for Diabetic Wound Microenvironment Reprogramming
- Injectable Macroporous Cryogels for Minimally Invasive Drug Delivery and Tissue Engineering
- Application of big data analytics in minoxidil drug development: a data-driven model for predicting efficacy and side effect risks
- Microneedles: A Promising Therapeutic Strategy for Next-Generation Drug Delivery, Diagnosis and Biosensing
- The Application Progress of Tumor Microenvironment-Responsive Drug Carriers in Precision Chemotherapy
- Response to “The Role of Patient‐ and Drug‐Related Factors in Oral Minoxidil and Pericardial Effusion: Analyses of Data From the United States Food and Drug Administration Adverse Event Reporting System”
- Predstanormix Duo – a new domestic combination drug for the treatment of lower urinary tract dysfunction symptoms associated with BPH.